State Street’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

State Street’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,791	Closed	-$55.1K	–	4758
2023 Q1	$55.1K	Hold	6,791	–	–	﹤0.01%	4478
2022 Q4	$80.5K	Hold	6,791	–	–	﹤0.01%	4432
2022 Q3	$94K	Hold	6,791	–	–	﹤0.01%	4484
2022 Q2	$238K	Hold	6,791	–	–	﹤0.01%	4122
2022 Q1	$271K	Buy	6,791 +788	+13%	+$33.8K	﹤0.01%	4276
2021 Q4	$254K	Hold	6,003	–	–	﹤0.01%	4245
2021 Q3	$408K	Hold	6,003	–	–	﹤0.01%	4057
2021 Q2	$462K	Buy	6,003 +5,362	+837%	+$327K	﹤0.01%	3887
2021 Q1	$42K	Buy	641 +91	+17%	+$7.09K	﹤0.01%	3949
2020 Q4	$19K	Hold	550	–	–	﹤0.01%	3869
2020 Q3	$30K	Hold	550	–	–	﹤0.01%	3785
2020 Q2	$21K	Hold	550	–	–	﹤0.01%	3768
2020 Q1	$14K	Hold	550	–	–	﹤0.01%	3717
2019 Q4	$27K	Hold	550	–	–	﹤0.01%	3755
2019 Q3	$27K	Hold	550	–	–	﹤0.01%	3754
2019 Q2	$50K	Sell	550 -273	-33%	-$33.2K	﹤0.01%	3725
2019 Q1	$122K	Sell	823 -8	-1%	-$1.55K	﹤0.01%	3625
2018 Q4	$131K	Sell	831 -8	-1%	-$1.53K	﹤0.01%	3615
2018 Q3	$206K	Buy	839 +29	+4%	+$6.87K	﹤0.01%	3599
2018 Q2	$182K	Buy	810 +79	+11%	+$21.2K	﹤0.01%	3577
2018 Q1	$179K	Buy	731 +43	+6%	+$11.3K	﹤0.01%	3566
2017 Q4	$212K	Buy	688 +104	+18%	+$34.2K	﹤0.01%	3557
2017 Q3	$214K	Buy	+584	New	+$207K	﹤0.01%	3597

Other funds holding DMK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

State Street's DMK Position: Q2 2023 in Review

State Street sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2023, closing a stake of 6,791 shares — an estimated $55.1K sold.

State Street first reported a position in DMK in Q3 2017 and held it in 23 quarters. The position peaked at $462K in Q2 2021. 22 funds tracked by Wall St. Rank hold DMK as of Q2 2023.

State Street reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2023 after selling out during the quarter.
State Street sold 6,791 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2023, an estimated $55.1K.
State Street first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q3 2017 and held it in 23 quarters.
State Street's DMK Pharmaceuticals Corporation Common Stock position peaked at $462K in Q2 2021.
22 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2023.

Based on State Street's 13F filing for Q2 2023, filed 14 Aug 2023.